Agios Pharmaceuticals, Inc.
AGIO · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $93 | $81 | $79 | $76 |
| Short-Term Investments | $860 | $858 | $814 | $817 |
| Receivables | $5 | $5 | $3 | $4 |
| Inventory | $32 | $31 | $30 | $28 |
| Other Curr. Assets | $43 | $45 | $42 | $40 |
| Total Curr. Assets | $1,033 | $1,019 | $969 | $966 |
| Property Plant & Equip (Net) | $44 | $47 | $51 | $55 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $304 | $400 | $531 | $638 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $4 | $4 | $5 | $5 |
| Total NC Assets | $353 | $452 | $587 | $698 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $1,386 | $1,471 | $1,556 | $1,663 |
| Liabilities | – | – | – | – |
| Payables | $20 | $18 | $14 | $17 |
| Short-Term Debt | $18 | $18 | $17 | $17 |
| Tax Payable | $0 | $0 | $1 | $1 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $37 | $35 | $21 | $47 |
| Total Curr. Liab. | $75 | $70 | $52 | $81 |
| LT Debt | $27 | $31 | $36 | $40 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $0 | $0 | $1 | $1 |
| Total NC Liab. | $27 | $31 | $37 | $41 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $27 | $49 | $53 | $57 |
| Total Liabilities | $101 | $102 | $89 | $122 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$454 | -$350 | -$238 | -$149 |
| AOCI | $2 | $1 | $0 | -$2 |
| Other Equity | $1,736 | $1,719 | $1,704 | $1,691 |
| Total Equity | $1,284 | $1,370 | $1,467 | $1,541 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $1,386 | $1,471 | $1,556 | $1,663 |
| Net Debt | -$48 | -$32 | -$26 | -$19 |